Pharmaceutical - Respiratory and Pulmonary

Filter

Current filters:

Respiratory and Pulmonary

Popular Filters

301 to 309 of 309 results

Mylan to acquire Pfizer generic respiratory delivery platform; challenge to GSK

10-11-2011

US generic drug major Mylan (Nasdaq: MYL) has entered into an agreement with global pharma behemoth Pfizer…

Advair DiskusGenericsGlaxoSmithKlineLicensingMylan LaboratoriesPfizerPharmaceuticalRespiratory and PulmonarySeretide

Vertex’ Kalydeco marks a milestone in fight against cystic fibrosis

06-11-2011

The oral drug ivacaftor (VX-770) provides major, sustained improvement in lung function, growth and other…

ivacaftorKalydecoPharmaceuticalRare diseasesResearchRespiratory and PulmonaryVertex

Anti-inflammatory therapeutics market to grow to $85.9 billion in 2017

06-11-2011

The anti-inflammatory therapeutics market accounted for $32.3 billion in 2002 from its seven major indications.…

Anti-Arthritics/RheumaticsGastro-intestinalsMarkets & MarketingNeurologicalPharmaceuticalRespiratory and Pulmonary

Vectura shares fall as partner Novartis reports US delay for lung cancer drug

26-10-2011

Shares of UK-based Vectura (LSE: VEC) tumbled 22% at 66 pence on Tuesday, after the company revealed…

NovartisPharmaceuticalRegulationResearchRespiratory and PulmonarySeebriVectura

Flutiform review to take longer than expected, says SkyePharma

19-10-2011

UK-based SkyePharma (LSE: SKP) revealed yesterday that the review of the European Marketing Authorization…

EuropeFlutiformMundi InternationalPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

Insmed tumbles as FDA continues hold on Ph III Arikace trial

11-10-2011

US biopharmaceutical company Insmed (Nasdaq CM: INSM) saw its share price plunge 32% to $2.95 in morning…

ArikaceBiotechnologyInsmedNorth AmericaPharmaceuticalRegulationResearchRespiratory and Pulmonary

Boehringer Ingelheim’s Combivent Respimat Inhalation Spray OKed in USA to replace aerosol

09-10-2011

The US Food and Drug Administration has approved German independent drug major Boehringer Ingelheim’s…

Boehringer IngelheimCombiventNorth AmericaPharmaceuticalRegulationRespiratory and Pulmonary

Almirall launches Nycomed’s COPD drug roflumilast in Spain; revises guidance

04-10-2011

Spain’s largest pharma company Almirall (ALM. MC) has just launched in Spain the second brand of…

AlmirallEuropeFinancialMarkets & MarketingPharmaceuticalRespiratory and Pulmonaryroflumilast

301 to 309 of 309 results

Back to top